Warren Point Capital, LLC was created to access and acquire minority positions in select emerging growth medical technology companies. WPC leverages a global network to identify and advise capital efficient portfolio companies approaching near-term value-inflection points. Founded in 2020, WPC is the General Partner of The Med-Tech Arbitrage Access Fund, LP. THE INFORMATION ON THIS PAGE IS INTENDED FOR THE MANAGEMENT OF GROWTH COMPANIES INTERESTED IN PARTNERING WITH WARREN POINT CAPITAL. IT IS NOT APPROPRIATE FOR ANY CURRENT OR PROSPECTIVE INVESTORS IN A WPC INVESTMENT VEHICLE AND SHOULD NOT BE CONSIDERED AN ACTUAL OR IMPLIED ENDORSEMENT OF ANY ADVICE, ANALYSIS, REPORT OR OTHER SERVICE RENDERED BY WPC.